Clinical Trials in Ramat Gan, Ramat Gan
3 recruiting
Showing 1–3 of 3 trials
Recruiting
Phase 2Phase 3
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
Advanced Melanoma
Eikon Therapeutics740 enrolled107 locationsNCT06697301
Recruiting
Phase 2
A Study of Selinexor (Seli) + Low-dose Dexamethasone (LDD) in Penta-refractory Multiple Myeloma (MM), Seli and Bortezomib + LDD in Triple-class Refractory MM.
Multiple Myeloma, Refractory
Karyopharm Therapeutics Inc127 enrolled16 locationsNCT04414475
Recruiting
Not Applicable
Early Transcatheter Mitral Valve Repair After Myocardial Infarction
Acute Mitral Regurgitation
Fundación para la Investigación Biosanitaria del Principado de Asturias250 enrolled32 locationsNCT06282042